Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:European Code Against Cancer, 5th edition : cancer-causing infections and related interventions
Authors:ID Alberts, Catharina Johanna (Author)
ID Bloem, Paul (Author)
ID de Sanjosé, Silvia (Author)
ID Graba, Sophie (Author)
ID Leja, Marcis (Author)
ID Malfertheiner, Peter (Author)
ID Matičič, Mojca (Author), et al.
Files:.pdf PDF - Presentation file, download (1,72 MB)
MD5: E32811D332ABD5B58B90186E8AF40CA6
 
URL URL - Source URL, visit https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70172
 
Language:English
Typology:1.02 - Review Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:The main infections that cause cancer in the European Union (EU) are Helicobacter pylori (H. pylori), human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Altogether, in 2022, these infections accounted for ~ 5% of all cancers in the EU, mainly of the stomach, cervix uteri and liver. The largest burden of infection-caused cancers was found in the south of the EU and near the eastern border. Substantial progress in the efficacy of interventions against these infections has been made since the release of the 4th edition of the European Code Against Cancer in 2015. Cancers due to infections can increasingly be prevented by prophylactic vaccines (HPV and HBV) and/or prompt diagnosis and treatment that can either cure (HCV and H. pylori) or slow down the infection (HBV and HIV), thus substantially reducing disease risk. Tools to tackle carcinogenic infections are also increasingly accessible and affordable in the EU, but their implementation is slow. Public awareness, political will and cost-effective protocols are necessary to establish large programmes of vaccination or testing and treatment. Progress monitoring, as well as avoiding disinformation and stigma, is crucial to ensure that advances in medical progress are fully leveraged. The recently published 5th edition of the European Code Against Cancer therefore recommends: (1) vaccinate girls and boys against HBV and HPV at the age recommended in your country; (2) take part in testing and treatment for HBV and HCV, HIV and H. pylori, as recommended in your country.
Keywords:Helicobacter pylori, HBV, HIV, European Code Against Cancer, cancer, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papillomavirus
Publication status:Published
Publication version:Version of Record
Year of publishing:2026
Number of pages:str. 96-116
Numbering:Vol. 20, issue 1
PID:20.500.12556/DiRROS-27242 New window
UDC:616.9
ISSN on article:1878-0261
DOI:10.1002/1878-0261.70172 New window
COBISS.SI-ID:266758403 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 30. 1. 2026;
Publication date in DiRROS:30.01.2026
Views:205
Downloads:96
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Molecular oncology
Publisher:Elsevier
ISSN:1878-0261
COBISS.SI-ID:527178265 New window

Document is financed by a project

Funder:EC - European Commission
Project number:10107524
Name:EU4Health programme
Acronym:EU4H

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back